Supplementary Figure Legend from Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients

MLA

Paola Nisticò, et al. Supplementary Figure Legend from Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients. Mar. 2023. EBSCOhost, https://doi.org/10.1158/0008-5472.22384434.

APA

Paola Nisticò, Luisa Imberti, Pier Giorgio Natali, Enrico Proietti, Filippo Belardelli, Caterina Catricalà, Virginia Ferraresi, Novella Gualtieri, Claudia Ghidini, Federico Serana, Alessandra Sottini, Duilia Del Bello, & Belinda Palermo. (2023). Supplementary Figure Legend from Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients. https://doi.org/10.1158/0008-5472.22384434

Chicago

Paola Nisticò, Luisa Imberti, Pier Giorgio Natali, Enrico Proietti, Filippo Belardelli, Caterina Catricalà, Virginia Ferraresi, et al. 2023. “Supplementary Figure Legend from Dacarbazine Treatment before Peptide Vaccination Enlarges T-Cell Repertoire Diversity of Melan-A–Specific, Tumor-Reactive CTL in Melanoma Patients,” March. doi:10.1158/0008-5472.22384434.